Changeflow GovPing Pharma & Drug Safety Patent Application for Hyaluronic Acid Producti...
Routine Notice Added Final

Patent Application for Hyaluronic Acid Production Stimulation

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published February 26th, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a new patent application (US20260083656A1) filed by Alastin Skincare, Inc. The application details compositions and methods for stimulating intrinsic hyaluronic acid production to improve skin moisture and elasticity. This is a routine publication of a patent application.

What changed

This document is a publication of a new patent application, US20260083656A1, filed by Alastin Skincare, Inc. The application pertains to compositions and methods designed to stimulate the body's natural production of hyaluronic acid, with the stated aim of enhancing skin moisture and elasticity.

As this is a patent application publication, it does not impose new regulatory obligations or deadlines on regulated entities. However, it may be of interest to pharmaceutical and cosmetic companies involved in skincare research and development, particularly those focusing on anti-aging or skin hydration technologies. Compliance officers should note this as a development in the intellectual property landscape for skincare ingredients.

Source document (simplified)

← USPTO Patent Applications

COMPOSITIONS AND METHODS RELATING TO STIMULATION OF HYALURONIC ACID

Application US20260083656A1 Kind: A1 Mar 26, 2026

Assignee

Alastin Skincare, Inc.

Inventors

Alan David Widgerow, John A. Garruto

Abstract

Compositions and methods for stimulating intrinsic hyaluronic acid production are provided herein. Compositions and methods for stimulating intrinsic hyaluronic acid production can improve skin moisture and elasticity.

CPC Classifications

A61K 8/64 A61K 8/35 A61K 8/553 A61K 8/735 A61K 8/9728 A61K 36/07 A61Q 19/00 A61K 2800/10 A61K 2800/78

Filing Date

2025-02-26

Application No.

19064198

View original document →

Classification

Agency
USPTO
Published
February 26th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083656A1

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Cosmetic Formulation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Cosmetics Biotechnology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.